MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
ADAP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Adaptimmune Therapeutics (ADAP) Ownership - Who owns Adaptimmune Therapeutics?

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
60 Jubilee Avenue
Phone
+44 1235430000
Employees
449
Web
https://www.adaptimmune.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
17.15M
P/E Ratio
N/A
Total Cash
26.06M
Projected Growth
N/A
Total Debt
48.68M
Revenue
65.09M
Risk (Beta)
3.80
Dividend Yield
N/A
Total Cash/Share
0.10
Total Debt/Equity
N/A
Revenue/Share
0.25 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for ADAP
A.I. Advisor
published General Information

General Information

a manufacturer of vaccines and cancer immunotherapy products

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
60 Jubilee Avenue
Phone
+44 1235430000
Employees
449
Web
https://www.adaptimmune.com